Monday, March 30, 2026
ADVT 
International

Indian-American judge slaps $1 mn fine on Facebook

Darpan News Desk IANS, 13 Feb, 2023 12:01 PM
  • Indian-American judge slaps $1 mn fine on Facebook
New York, Feb 13 (IANS) Indian-American judge Vince Chhabria has slapped a fine of almost $1 million on Meta, Facebook's parent company, and its law firm for creating obstacles for court and users in a data breach trial.

According to a Bloomberg report, District Judge Chhabria wrote in an order that the fine is "loose change" for Facebook and Gibson Dunn & Crutcher LLP for deceitfully denying that it shared users' private information with third parties.

The San Francisco judge said that Facebook relied on "delay, misdirection, and frivolous arguments" to make the litigation unfairly difficult and expensive. "Perhaps realising they had no real argument for withholding these documents, Facebook and Gibson Dunn contorted various statements" of opposing lawyers and the court acebeyond recognition," Chhabria wrote, according to Bloomberg.

"And again, after being told repeatedly that these arguments made no sense, Facebook and Gibson Dunn insisted on pressing them," he said.

The judge added that Facebook also attempted to push the users, who had filed a complaint against it, into settling for a lesser compensation.

The lawsuit was filed in a California court on behalf of Facebook users impacted by Meta's partnership with research firm Cambridge Analytica.

The $925,078.51 penalty comes after Meta had agreed a $725 million settlement in December 2022 to resolve a class-action lawsuit, which claimed that Facebook illegally shared user data with Cambridge Analytica.

In March 2018, whistleblower Christopher Wylie publicly revealed that Cambridge Analytica exfiltrated personal data of 87 million Facebook users in the US in order to influence the results of the 2016 US presidential election.

This data trove included Facebook users' ages, interests, pages they liked, groups they followed, physical locations, political and religious affiliations, relationships, and photos, as well as their full names, phone numbers, and email addresses.

 

MORE International ARTICLES

Lilly seeks emergency use of its antibody drug for COVID-19

Lilly seeks emergency use of its antibody drug for COVID-19
Eli Lilly and Company announced the partial results Wednesday in a news release; they have not yet been published or reviewed by independent scientists.

Lilly seeks emergency use of its antibody drug for COVID-19

Experts call Trump's rosy virus message misguided

Experts call Trump's rosy virus message misguided
The seven-day rolling average for new U.S. cases has climbed over the past two weeks to almost 42,000 per day. The nation also sees more than 700 COVID-19 deaths each day.

Experts call Trump's rosy virus message misguided

With Trump sick, all eyes on Wednesday's VP debate

With Trump sick, all eyes on Wednesday's VP debate
Questions persist about Donald Trump's health following his COVID-19 diagnosis, as well as the age of 77-year-old challenger Joe Biden.

With Trump sick, all eyes on Wednesday's VP debate

Magnitsky sanctions demanded in Iranian shootdown

Magnitsky sanctions demanded in Iranian shootdown
There were 176 people killed when the Iranian military shot down Ukraine International Airlines Flight PS752 on Jan. 8, shortly after it took off from Tehran.

Magnitsky sanctions demanded in Iranian shootdown

Berry scare: U.S. eyeing foreign produce imports

Berry scare: U.S. eyeing foreign produce imports
U.S. Trade Representative Robert Lighthizer served notice last week that the Trump administration fears domestic producers are being unfairly harmed by what they call a recent increase in berry imports from Canada and Mexico.

Berry scare: U.S. eyeing foreign produce imports

EU regulator starts safety review of coronavirus drug

EU regulator starts safety review of coronavirus drug
In a statement on Friday, the EU regulator said it isn’t clear whether remdesivir was causing the “acute kidney injury,” but that the issue “warrants further investigation.”

EU regulator starts safety review of coronavirus drug